Mariusz P. Gajewski
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: University of Idaho (2001–2005); University of Montana (2007–2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mariusz P. Gajewski's research focuses on the design, synthesis, and characterization of novel chemical compounds, particularly those with potential therapeutic applications. His work has investigated inhibitors of the xC− transport system, aiming to reduce microglial glutamate release and subsequent neurotoxicity. This research is relevant to understanding and potentially treating conditions like glioblastoma. Gajewski has also explored the activity of specific chemical analogs, such as 10-alkoxy-anthracenyl-isoxazoles, against glioblastoma cell lines. His scholarly output includes 17 publications, with an h-index of 6 and 109 total citations. Gajewski has collaborated with Steven W. Barger of the University of Arkansas for Medical Sciences on several projects.
Metrics
- h-index: 6
- Publications: 18
- Citations: 110
Selected Publications
-
Design, synthesis, and characterization of novel system xC− transport inhibitors: inhibition of microglial glutamate release and neurotoxicity (2023)
-
Design, synthesis, and characterization of novel Xc- transport inhibitors: Inhibition of microglial glutamate release and neurotoxicity (2023)
-
10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line (2022)
-
AIMing towards improved antitumor efficacy (2015)
Collaboration Network
Top Collaborators
- Design, synthesis, and characterization of novel system xC− transport inhibitors: inhibition of microglial glutamate release and neurotoxicity
- Design, synthesis, and characterization of novel Xc- transport inhibitors: Inhibition of microglial glutamate release and neurotoxicity
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
Similar Researchers
Based on overlapping research topics